Prescription drug · NDA
Mimrylo (Rusfertide) NDC 63020-765
Kit · Subcutaneous · Takeda Pharmaceuticals America, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63020-765-60 | 6302007656063020076560 | 1 KIT in 1 CARTON (63020-765-60) * 54 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63020-760-60) * .6 mL in 1 SYRINGE (63020-600-05)Marketed from Aug 28, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Mimrylo
- Generic name (nonproprietary)
- rusfertide
- Dosage form
- Kit
- Route
- Subcutaneous
- Labeler
- Takeda Pharmaceuticals America, Inc.NDC labeler code 63020
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 220605
- Marketing start
- Listing expires
- Identifiers
- Product ID 63020-765_2fc41c37-8a81-4171-a52c-e9317c0c34cfSPL ID 2fc41c37-8a81-4171-a52c-e9317c0c34cfSPL set ID 101aff01-31ed-4841-a8b6-0a5a8503189bRxCUI 2751601, 2751606, 2751608, 2751610, 2751612, 2751614, 2751616, 2751618, 2751620, 2751622
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N463020076560followed by a unit qualifier and the quantityPackage 63020-0765-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
MIMRYLO is indicated for the treatment of erythrocytosis in adults with polycythemia vera (PV). MIMRYLO is a hepcidin mimetic indicated for the treatment of erythrocytosis in adults with polycythemia vera (PV). ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 63020-765
- What is NDC 63020-765?
- 63020-765 is the product NDC for Mimrylo (rusfertide) kit, listed with the FDA by Takeda Pharmaceuticals America, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Mimrylo (Rusfertide).
- Who is the labeler?
- Takeda Pharmaceuticals America, Inc., NDC labeler code 63020. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Mimrylo?
- 4 other product NDCs are listed under this name. See all Mimrylo NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Mimrylo products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Mimrylorusfertide | — | KitSubcutaneous | Takeda Pharmaceuticals America, Inc. | 63020-715 | 63020-0715-10 |
| Mimrylorusfertide | — | KitSubcutaneous | Takeda Pharmaceuticals America, Inc. | 63020-725 | 63020-0725-20 |
| Mimrylorusfertide | — | KitSubcutaneous | Takeda Pharmaceuticals America, Inc. | 63020-735 | 63020-0735-30 |
| Mimrylorusfertide | — | KitSubcutaneous | Takeda Pharmaceuticals America, Inc. | 63020-745 | 63020-0745-40 |
Other NDCs under NDA 220605
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Mimrylorusfertide | — | KitSubcutaneous | Takeda Pharmaceuticals America, Inc. | 63020-715 |
| Mimrylorusfertide | — | KitSubcutaneous | Takeda Pharmaceuticals America, Inc. | 63020-725 |
| Mimrylorusfertide | — | KitSubcutaneous | Takeda Pharmaceuticals America, Inc. | 63020-735 |
| Mimrylorusfertide | — | KitSubcutaneous | Takeda Pharmaceuticals America, Inc. | 63020-745 |